Charlotte C. Schmitt

Paris, 75013, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial.

Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial.

Journal: Nature communications
Published: February 23, 2023

Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening Increases Anti-Programmed Death-Ligand 1 Delivery and Efficacy in Gl261 Mouse Model.

Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening Increases Anti-Programmed Death-Ligand 1 Delivery and Efficacy in Gl261 Mouse Model.

Journal: Pharmaceutics
Published: December 08, 2022

Identification of growth hormone receptor as a relevant target for precision medicine in low-EGFR expressing glioblastoma.

Identification of growth hormone receptor as a relevant target for precision medicine in low-EGFR expressing glioblastoma.

Journal: Clinical and translational medicine
Published: January 25, 2022

PAK3 is a key signature gene of the glioma proneural subtype and affects its proliferation, differentiation and growth.

PAK3 is a key signature gene of the glioma proneural subtype and affects its proliferation, differentiation and growth.

Journal: Cellular oncology (Dordrecht, Netherlands)
Published: September 01, 2021

Biodegraded magnetosomes with reduced size and heating power maintain a persistent activity against intracranial U87-Luc mouse GBM tumors.

Biodegraded magnetosomes with reduced size and heating power maintain a persistent activity against intracranial U87-Luc mouse GBM tumors.

Journal: Journal of nanobiotechnology
Published: September 21, 2019

Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.

Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.

Journal: Journal of neuro-oncology
Published: February 26, 2019

Correction to: ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.

Correction to: ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.

Journal: Journal of neuro-oncology
Published: March 18, 2018

ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.

ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.

Journal: Journal of neuro-oncology
Published: July 17, 2017

Development of non-pyrogenic magnetosome minerals coated with poly-l-lysine leading to full disappearance of intracranial U87-Luc glioblastoma in 100% of treated mice using magnetic hyperthermia.

Development of non-pyrogenic magnetosome minerals coated with poly-l-lysine leading to full disappearance of intracranial U87-Luc glioblastoma in 100% of treated mice using magnetic hyperthermia.

Journal: Biomaterials
Published: April 04, 2017

Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing.

Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing.

Journal: Acta neuropathologica
Published: March 03, 2017

Chains of magnetosomes with controlled endotoxin release and partial tumor occupation induce full destruction of intracranial U87-Luc glioma in mice under the application of an alternating magnetic field.

Chains of magnetosomes with controlled endotoxin release and partial tumor occupation induce full destruction of intracranial U87-Luc glioma in mice under the application of an alternating magnetic field.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 03, 2017

Enhanced antitumor efficacy of biocompatible magnetosomes for the magnetic hyperthermia treatment of glioblastoma.

Enhanced antitumor efficacy of biocompatible magnetosomes for the magnetic hyperthermia treatment of glioblastoma.

Journal: Theranostics
Published: December 26, 2016
Showing 1-12 of 20

Last Updated: 09/26/2026